# Graft ischemia post cell transplantation to the brain: Glucose deprivation as the primary driver of rapid cell death

## TL;DR

This study finds that lack of glucose, not oxygen, is the main cause of cell death after brain cell transplants, challenging previous assumptions.

## Contribution

The study identifies glucose deprivation as the primary driver of rapid cell death in transplanted brain grafts, overturning the common belief about hypoxia.

## Key findings

- Neuron progenitor cells and VM cells remained viable in severe hypoxia, contradicting hypoxia-induced death theories.
- Glucose deprivation was shown to be the main driver of cell death in ischemic conditions.
- Glucose supplementation via osmotic minipumps did not improve cell survival in transplanted cells.

## Abstract

Replacing cells lost during the progression of neurodegenerative disorders holds potential as a therapeutic strategy. Unfortunately, the majority of cells die post-transplantation, which creates logistical and biological challenges for cell therapy approaches. The cause of cell death is likely to be multifactorial in nature but has previously been correlated with hypoxia in the graft core. Here we use mathematical modelling to highlight that grafted cells experiencing hypoxia will also face a rapid decline in glucose availability. Interestingly, three neuron progenitor types derived from stem cell sources, and primary human fetal ventral mesencephalic (VM) cells all remained highly viable in severe hypoxia (0.1 ​% oxygen), countering the idea of rapid hypoxia-induced death in grafts. However, we demonstrate that glucose deprivation, not a paucity of oxygen, was a driver of rapid cell death, which was compounded in ischemic conditions of both oxygen and glucose deprivation. Supplementation of glucose to rat embryonic VM cells transplanted to the adult rat brain failed to improve survival at the dose administered and highlighted the problems of using osmotic minipumps in assisting neural grafting. The data shows that maintaining sufficient glucose in grafts is likely to be of critical importance for cell survival, but better means of achieving sustained glucose delivery is required.

Image 1